Literature DB >> 30229909

Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.

Kevin M Elias1,2,3, Petros Tsantoulis4,5, Jean-Christophe Tille6, Allison Vitonis7, Leona A Doyle3,8, Jason L Hornick3,8, Gurkan Kaya4,9, Laurent Barnes9, Daniel W Cramer3,7, Giacomo Puppa6, Sarah Stuckelberger10, Jagmohan Hooda10, Pierre-Yves Dietrich4,5, Michael Goggins11, Candace L Kerr12, Michael Birrer13, Michelle S Hirsch3,8, Ronny Drapkin10, Sana Intidhar Labidi-Galy4,5.   

Abstract

Mucinous ovarian tumors (MOTs) morphologically and epidemiologically resemble mucinous cystic neoplasms (MCNs) of the pancreas, sharing a similar stroma and both occurring disproportionately among young females. Additionally, MOTs and MCNs share similar clinical characteristics and immunohistochemical phenotypes. Exome sequencing has revealed frequent recurrent mutations in KRAS and RNF43 in both MOTs and MCNs. The cell of origin for these tumors remains unclear, but MOTs sometimes arise in the context of mature cystic teratomas and other primordial germ cell (PGC) tumors. We undertook the present study to investigate whether non-teratoma-associated MOTs and MCNs share a common cell of origin. Comparisons of the gene expression profiles of MOTs [including both the mucinous borderline ovarian tumors (MBOTs) and invasive mucinous ovarian carcinomas (MOCs)], high-grade serous ovarian carcinomas, ovarian surface epithelium, Fallopian tube epithelium, normal pancreatic tissue, pancreatic duct adenocarcinomas, MCNs, and single-cell RNA-sequencing of PGCs revealed that both MOTs and MCNs are more closely related to PGCs than to either eutopic epithelial tumors or normal epithelia. We hypothesize that MCNs may arise from PGCs that stopped in the dorsal pancreas during their descent to the gonads during early human embryogenesis, while MOTs arise from PGCs in the ovary. Together, these data suggest a common pathway for the development of MCNs and MOTs, and suggest that these tumors may be more properly classified as germ cell tumor variants.
Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  RHOB; mucinous cystic neoplasm; mucinous ovarian tumor; pathogenesis; primordial germ cells

Mesh:

Year:  2018        PMID: 30229909      PMCID: PMC6240919          DOI: 10.1002/path.5161

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

1.  Human housekeeping genes are compact.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Trends Genet       Date:  2003-07       Impact factor: 11.639

2.  Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases.

Authors:  Peiguo G Chu; Lawrence Chung; Lawrence M Weiss; Sean K Lau
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

Review 3.  Cystic precursors to invasive pancreatic cancer.

Authors:  Hanno Matthaei; Richard D Schulick; Ralph H Hruban; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03       Impact factor: 46.802

Review 4.  Mucinous tumors of the ovary: current thoughts on diagnosis and management.

Authors:  Jubilee Brown; Michael Frumovitz
Journal:  Curr Oncol Rep       Date:  2014-06       Impact factor: 5.075

5.  Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.

Authors:  Noriyoshi Fukushima; Norihiro Sato; Nijaguna Prasad; Steven D Leach; Ralph H Hruban; Michael Goggins
Journal:  Oncogene       Date:  2004-12-02       Impact factor: 9.867

6.  RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.

Authors:  Georgina L Ryland; Sally M Hunter; Maria A Doyle; Simone M Rowley; Michael Christie; Prue E Allan; David D L Bowtell; Kylie L Gorringe; Ian G Campbell
Journal:  J Pathol       Date:  2013-02       Impact factor: 7.996

7.  Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.

Authors:  Stefano Crippa; Roberto Salvia; Andrew L Warshaw; Ismael Domínguez; Claudio Bassi; Massimo Falconi; Sarah P Thayer; Giuseppe Zamboni; Gregory Y Lauwers; Mari Mino-Kenudson; Paola Capelli; Paolo Pederzoli; Carlos Fernández-del Castillo
Journal:  Ann Surg       Date:  2008-04       Impact factor: 12.969

8.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

Authors:  Huadong Pei; Liang Li; Brooke L Fridley; Gregory D Jenkins; Krishna R Kalari; Wilma Lingle; Gloria Petersen; Zhenkun Lou; Liewei Wang
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer.

Authors:  Pamela Maris; Arnaud Blomme; Ana Perez Palacios; Brunella Costanza; Akeila Bellahcène; Elettra Bianchi; Stephanie Gofflot; Pierre Drion; Giovanna Elvi Trombino; Emmanuel Di Valentin; Pino G Cusumano; Sylvie Maweja; Guy Jerusalem; Philippe Delvenne; Eric Lifrange; Vincent Castronovo; Andrei Turtoi
Journal:  PLoS Med       Date:  2015-09-01       Impact factor: 11.069

View more
  9 in total

1.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 2.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

Review 3.  The tubal epigenome - An emerging target for ovarian cancer.

Authors:  Hunter D Reavis; Ronny Drapkin
Journal:  Pharmacol Ther       Date:  2020-03-18       Impact factor: 12.310

Review 4.  The cellular origins of cancer with particular reference to the gastrointestinal tract.

Authors:  Malcolm R Alison
Journal:  Int J Exp Pathol       Date:  2020-08-14       Impact factor: 1.925

5.  Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas.

Authors:  Li-Qi Sun; Li-Si Peng; Jie-Fang Guo; Fei Jiang; Fang Cui; Hao-Jie Huang; Zhen-Dong Jin
Journal:  World J Gastroenterol       Date:  2021-02-14       Impact factor: 5.742

6.  Intralobular distribution of ovarian-like stroma in pancreatic mucinous cystic neoplasms: a discussion on its tumorigenesis.

Authors:  Yuki Fukumura; Yuko Kinowaki; Yoko Matsuda; Masaru Takase; Momoko Tonosaki; Masaaki Minagawa; Akio Saiura; Minoru Tanabe; Keiichi Okano; Yasuyuki Suzuki; Kota Kato; Takashi Yao
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

Review 7.  Germline stem cells in human.

Authors:  Hanhua Cheng; Dantong Shang; Rongjia Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-10-02

Review 8.  To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm.

Authors:  Massimo De Felici; Francesca Gioia Klinger; Federica Campolo; Carmela Rita Balistreri; Marco Barchi; Susanna Dolci
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.

Authors:  Rosario I Corona; Ji-Heui Seo; Xianzhi Lin; Dennis J Hazelett; Jessica Reddy; Marcos A S Fonseca; Forough Abassi; Yvonne G Lin; Paulette Y Mhawech-Fauceglia; Sohrab P Shah; David G Huntsman; Alexander Gusev; Beth Y Karlan; Benjamin P Berman; Matthew L Freedman; Simon A Gayther; Kate Lawrenson
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.